Cytokinetics Inc. buy SVB Leerink LLC
Start price
26.02.26
/
50%
€53.50
Target price
26.02.27
€71.07
Performance (%)
-3.18%
Price
28.04.26
€51.80
Summary
This prediction is currently active. With a performance of -3.18%, the BUY prediction for Cytokinetics Inc. by SVB_Leerink_LLC is down slightly. This prediction currently runs until 26.02.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -7.698% | -7.698% |
| iShares Core DAX® | -0,37 % | 8,40 % |
| iShares Nasdaq 100 | 2,27 % | 15,23 % |
| iShares Nikkei 225® | 1,43 % | 14,42 % |
| iShares S&P 500 | 1,22 % | 10,49 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by Leerink Partners from $83.00 to $84.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.80
15.08.23
15.08.23
€53.00
15.08.24
15.08.24
76.17%
16.08.24
16.08.24
